Phospho-Aspirin (MDC-22) inhibits pancreatic cancer growth in patient-derived tumor xenografts and KPC mice by targeting EGFR: Enhanced efficacy in combination with irinotecan
2017 ◽
Vol 51
(4)
◽
pp. 1035-1044
◽
Keyword(s):
Keyword(s):
2010 ◽
Vol 9
(5)
◽
pp. 1136-1146
◽
Keyword(s):
Keyword(s):